Skip to content
Nikang Therapeutics
About Us
Science & Pipeline
News
Careers
Home
About us
Science & Pipeline
News
Careers
NiKang Therapeutics Enters Into Clinical Trial Collaboration and Supply Agreement to Evaluate NKT2152 in Combination with Standard-of-Care in First-Line Advanced Hepatocellular Carcinoma
See the press release on
Business Wire